» Articles » PMID: 37405465

The Current Evidence on Surgical Management for Synchronous Bilateral Renal Tumors: Results from a Scoping Review

Overview
Journal World J Urol
Specialty Urology
Date 2023 Jul 5
PMID 37405465
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Synchronous bilateral renal masses (SBRM) account for a low percentage of kidney tumors, and there is no current recommendation for their management. The objective was to review evidence regarding the best surgical approach for SBRM in terms of type and timing of surgery.

Methods: A broad literature search was performed on 28th January 2023 using Scopus, PubMed, and EMBASE. Only English papers dealing with adults were included. Meeting abstracts were excluded.

Results: Twenty-four papers were accepted and included. SBRM behave less aggressively than metachronous tumors, and partial nephrectomy (PN) is the preferred therapeutic option to preserve renal function. Open, laparoscopic, and robot-assisted approaches were found to be similar in oncological outcomes, though robot-assisted surgery resulted in lower comorbidities. Same-sitting PN was demonstrated to be a safe approach, particularly in the robotic-assisted one. Finally, the same-siting and staged NSS were similar in preserving renal function.

Conclusions: PN should be the desirable treatment for SBRM whenever feasible and if patients are fit, but surgeon expertise should also be taken into the account.

Citing Articles

The long-term survival outcome of sporadic bilateral renal cell carcinoma and optimization of surgical treatment: a large-scale population-based cohort study.

Deng R, Qiu J, Shang J, Yu C, Tian P, Zhao Z Clin Exp Med. 2024; 25(1):20.

PMID: 39708253 PMC: 11663156. DOI: 10.1007/s10238-024-01535-5.


Assessing flexible ureteroscopy outcomes for lower Pole versus non lower Pole stones using the flexible and navigable suction ureteric access sheath: a prospective multicenter study by EAU Endourology and PEARLS group.

Shrestha A, Traxer O, Seitz C, Corrales M, Castellani D, Chew B World J Urol. 2024; 43(1):41.

PMID: 39704866 DOI: 10.1007/s00345-024-05384-5.


DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications.

Jing X, Qin X, Liu H, Liu H, Wang H, Qin J Eur J Med Res. 2024; 29(1):107.

PMID: 38326910 PMC: 10848511. DOI: 10.1186/s40001-024-01678-x.


Near-Infrared Fluorescence Imaging with Indocyanine Green for Robot-Assisted Partial Nephrectomy: A Systematic Review and Meta-Analysis.

Giulioni C, Mulawkar P, Castellani D, De Stefano V, Nedbal C, Gadzhiev N Cancers (Basel). 2023; 15(23).

PMID: 38067266 PMC: 10705226. DOI: 10.3390/cancers15235560.


Flexible ureteroscopy for lower pole calculus: is it still a challenge?.

Shrestha A, Adhikari B, Panthier F, Baidya S, Gauhar V, Traxer O World J Urol. 2023; 41(11):3345-3353.

PMID: 37728745 DOI: 10.1007/s00345-023-04606-6.

References
1.
Roy A, Le O, Silverman P, Kundra V . Common and uncommon bilateral adult renal masses. Cancer Imaging. 2012; 12:205-11. PMC: 3390750. DOI: 10.1102/1470-7330.2012.0022. View

2.
Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam J . Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 2022; 82(5):529-542. DOI: 10.1016/j.eururo.2022.08.019. View

3.
Makino T, Kadomoto S, Izumi K, Mizokami A . Epidemiology and Prevention of Renal Cell Carcinoma. Cancers (Basel). 2022; 14(16). PMC: 9406474. DOI: 10.3390/cancers14164059. View

4.
Phelan M . Small renal mass with contralateral large renal mass: remove large renal mass first in staged fashion. Pro. J Urol. 2012; 188(1):18-9. DOI: 10.1016/j.juro.2012.04.032. View

5.
Patel A, Lee B, Campbell S, Zhou M, Fergany A . Bilateral synchronous sporadic renal tumors: pathologic concordance and clinical implications. Urology. 2011; 78(5):1095-9. DOI: 10.1016/j.urology.2011.06.051. View